Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03379545 · ClinicalTrials.gov registry record · NA
3D MR Versus 3D CT for Glenohumeral Arthritis
A NA study, sponsored by NYU Langone Health.
- Completed
- Registry status
- NA
- Development phase
- 31
- Enrollment target
NCT03379545: Completed NA study, sponsored by NYU Langone Health.
NCT03379545 is a NA study that has completed, run by NYU Langone Health. The registered enrollment target is 31 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03379545, a NA study, has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 31 participants
- Enrollment target
Study Summary
This study aims to assess the efficacy of three-dimensional magnetic resonance (MR) compared to three-dimensional computed tomography (CT) imaging. This proposed study is a prospective, unrandomized, single-blinded, self-controlled, and single-armed diagnostic radiological evaluation study.
Primary Outcome
All scans from 3D CT and 3D MR imaging were reviewed carefully for the presence of any morphological changes. For the determination of glenoid version, a line was drawn between the anterior and posterior margins of the glenoid. The transverse axis of the scapula was determined by a line drawn from the midpoint of the genoid fossa to the medial end of the image of the scapula; a line drawn perpendicular to this was defined as a line of neutral version. The angle between the line of neutral versio
Interventions
- DIAGNOSTIC_TEST 3-dimensional (3D) magnetic resonance (MR) imaging
- DIAGNOSTIC_TEST 3D computed tomography (CT) imaging
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 31 participants |
| Start Date | 2017-01-11 |
| Est. Completion | 2020-06-05 |
| Phase | NA |
What the finished NCT03379545 record still lists
NCT03379545 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 31 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 2 interventions - of which 3-dimensional (3D) magnetic resonance (MR) imaging is the first listed.
NCT03379545 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03379545 about?
NCT03379545 is a clinical study titled "3D MR Versus 3D CT for Glenohumeral Arthritis". This study aims to assess the efficacy of three-dimensional magnetic resonance (MR) compared to three-dimensional computed tomography (CT) imaging. This proposed study is a prospective, unrandomized, single-blinded, self-controlled, and single-armed diagnostic radiological evaluation study.
What is the current status of trial NCT03379545?
This trial is currently completed. It is a NA study. The enrollment target is 31 participants. The study started on 2017-01-11. Estimated completion is 2020-06-05.
What interventions are being tested in trial NCT03379545?
The interventions under investigation include: 3-dimensional (3D) magnetic resonance (MR) imaging (DIAGNOSTIC_TEST), 3D computed tomography (CT) imaging (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03379545?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03379545's enrollment target sits among peer trials
31 1592nd of 2000 higher than 408 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02932618 · 31 participants · Phase 3
A Study of Recombinant Von Willebrand Factor (rVWF) With or Without ADVATE in Children With Severe Von Willebrand Disease (VWD)
- NCT03482297 · 31 participants · Phase 1
Automated Abdominal Binder for Orthostatic Hypotension
- NCT04016389 · 31 participants · NA
FIGO 2018 Stage IB2 Cervical Cancer Treated With Neoadjuvant Chemotherapy Followed by Fertility Sparing Surgery
- NCT04211675 · 31 participants · Phase 1
NK Cells Infusions With Irinotecan, Temozolomide, and Dinutuximab
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI